KRTAP6-1
gene geneOn this page
Also known as KAP6.1C21orf103
Summary
KRTAP6-1 (keratin associated protein 6-1, HGNC:18931) is a protein-coding gene on chromosome 21q22.11, encoding Keratin-associated protein 6-1 (Q3LI64). In the hair cortex, hair keratin intermediate filaments are embedded in an interfilamentous matrix, consisting of hair keratin-associated proteins (KRTAP), which are essential for the formation of a rigid and resistant hair shaft through their extensive disulfide bond cross-link….
Predicted to be involved in keratinization. Located in cytosol.
Source: NCBI Gene 337966 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 15 total
- MANE Select transcript:
NM_181602
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:18931 |
| Approved symbol | KRTAP6-1 |
| Name | keratin associated protein 6-1 |
| Location | 21q22.11 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | KAP6.1, C21orf103 |
| Ensembl gene | ENSG00000184724 |
| Ensembl biotype | protein_coding |
| Entrez | 337966 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000329122
RefSeq mRNA: 1 — MANE Select: NM_181602
NM_181602
CCDS: CCDS13602
Canonical transcript exons
ENST00000329122 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001540538 | 30613431 | 30613930 |
Expression profiles
Bgee: expression breadth broad, 12 present calls, max score 37.47.
Top tissues by expression
120 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| sural nerve | UBERON:0015488 | 37.47 | gold quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| bone marrow cell | CL:0002092 | 36.16 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 35.73 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| muscle tissue | UBERON:0002385 | 32.79 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| bone marrow | UBERON:0002371 | 31.74 | gold quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| prefrontal cortex | UBERON:0000451 | 29.50 | silver quality |
| primary visual cortex | UBERON:0002436 | 29.16 | silver quality |
| duodenum | UBERON:0002114 | 28.14 | gold quality |
| liver | UBERON:0002107 | 28.04 | gold quality |
| lymph node | UBERON:0000029 | 27.57 | gold quality |
| skin of abdomen | UBERON:0001416 | 27.16 | gold quality |
| tonsil | UBERON:0002372 | 27.05 | gold quality |
| leukocyte | CL:0000738 | 26.85 | gold quality |
| monocyte | CL:0000576 | 26.78 | gold quality |
| islet of Langerhans | UBERON:0000006 | 26.55 | gold quality |
| vermiform appendix | UBERON:0001154 | 26.42 | gold quality |
| blood | UBERON:0000178 | 26.10 | gold quality |
| gall bladder | UBERON:0002110 | 25.98 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 25.89 | gold quality |
| placenta | UBERON:0001987 | 25.81 | gold quality |
| urinary bladder | UBERON:0001255 | 25.72 | gold quality |
| zone of skin | UBERON:0000014 | 25.59 | gold quality |
| muscle of leg | UBERON:0001383 | 25.02 | gold quality |
| skin of leg | UBERON:0001511 | 24.31 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.98 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 1)
- Expressed and purified are a high sulfur KAP (KAP11.1) and a high glycine-tyrosine KAP (KAP6.1). (PMID:29391282)
Cross-species orthologs
0 orthologs
Protein
Protein identifiers
Keratin-associated protein 6-1 — Q3LI64 (reviewed: Q3LI64)
All UniProt accessions (1): Q3LI64
UniProt curated annotations — full annotation on UniProt →
Function. In the hair cortex, hair keratin intermediate filaments are embedded in an interfilamentous matrix, consisting of hair keratin-associated proteins (KRTAP), which are essential for the formation of a rigid and resistant hair shaft through their extensive disulfide bond cross-linking with abundant cysteine residues of hair keratins. The matrix proteins include the high-sulfur and high-glycine-tyrosine keratins.
Subunit / interactions. Interacts with hair keratins.
Similarity. Belongs to the KRTAP type 6 family.
RefSeq proteins (1): NP_853633* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR040313 | KAP6 | Family |
UniProt features (1 total): chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q3LI64-F1 | 43.85 | 0.00 |
Function
Pathways and Gene Ontology
Reactome pathways
2 pathways
| ID | Pathway |
|---|---|
| R-HSA-6805567 | Keratinization |
| R-HSA-1266738 | Developmental Biology |
MSigDB gene sets: 38 (showing top):
GOBP_EPITHELIUM_DEVELOPMENT, DARWICHE_SKIN_TUMOR_PROMOTER_DN, DARWICHE_PAPILLOMA_RISK_LOW_UP, DARWICHE_PAPILLOMA_RISK_HIGH_DN, DARWICHE_SQUAMOUS_CELL_CARCINOMA_DN, DARWICHE_PAPILLOMA_PROGRESSION_RISK, GGGTGGRR_PAX4_03, GOBP_EPIDERMAL_CELL_DIFFERENTIATION, HOWLIN_PUBERTAL_MAMMARY_GLAND, MARTINEZ_RB1_TARGETS_DN, SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM6, GOBP_EPIDERMIS_DEVELOPMENT, POU3F2_02, GOBP_KERATINIZATION, chr21q22
GO Biological Process (1): keratinization (GO:0031424)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (2): cytosol (GO:0005829), intermediate filament (GO:0005882)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Developmental Biology | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| keratinocyte differentiation | 1 |
| multicellular organismal process | 1 |
| binding | 1 |
| cytoplasm | 1 |
| cellular anatomical structure | 1 |
| intermediate filament cytoskeleton | 1 |
| polymeric cytoskeletal fiber | 1 |
Protein interactions and networks
STRING
186 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| KRTAP6-1 | KRTAP22-1 | Q3MIV0 | 877 |
| KRTAP6-1 | KRTAP6-3 | Q3LI67 | 870 |
| KRTAP6-1 | KRTAP20-1 | Q3LI63 | 791 |
| KRTAP6-1 | KRTAP6-2 | Q3LI66 | 791 |
| KRTAP6-1 | KRTAP20-2 | Q3LI61 | 782 |
| KRTAP6-1 | KRTAP26-1 | Q6PEX3 | 769 |
| KRTAP6-1 | KRTAP8-1 | Q8IUC2 | 767 |
| KRTAP6-1 | KRTAP24-1 | Q3LI83 | 723 |
| KRTAP6-1 | SCYGR1 | A0A286YEY9 | 720 |
| KRTAP6-1 | KRTAP15-1 | Q3LI76 | 720 |
| KRTAP6-1 | KRTAP7-1 | Q8IUC3 | 701 |
| KRTAP6-1 | KRTAP13-3 | Q3SY46 | 690 |
| KRTAP6-1 | A8MUN0 | A8MUN0 | 669 |
| KRTAP6-1 | KRTAP11-1 | Q8IUC1 | 659 |
| KRTAP6-1 | KRTAP1-1 | Q07627 | 626 |
IntAct
293 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| TRIP13 | KRTAP6-1 | psi-mi:“MI:0915”(physical association) | 0.600 |
| GLIS3 | KRTAP6-1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| VENTX | KRTAP6-1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| HOXC8 | KRTAP6-1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| NOTO | KRTAP6-1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MAGED1 | KRTAP6-1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CCDC24 | KRTAP6-1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MED25 | KRTAP6-1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TENT5B | KRTAP6-1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CATSPER1 | KRTAP6-1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP6-1 | KRTAP12-3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KPRP | KRTAP6-1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GPS2 | KRTAP6-1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MAPK1IP1L | KRTAP6-1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CRYAB | KRTAP6-1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CAMK2G | KRTAP6-1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP6-1 | CAMK2A | psi-mi:“MI:0915”(physical association) | 0.560 |
| TNIP1 | KRTAP6-1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| VAC14 | KRTAP6-1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CYSRT1 | KRTAP6-1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| DAZAP2 | KRTAP6-1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP6-1 | ITIH6 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP6-1 | GLIS2 | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (103): KRTAP6-1 (Two-hybrid), KRTAP6-1 (Two-hybrid), KRTAP6-1 (Two-hybrid), KRTAP6-1 (Two-hybrid), KRTAP6-1 (Two-hybrid), KRTAP6-1 (Two-hybrid), KRTAP6-1 (Two-hybrid), KRTAP6-1 (Two-hybrid), KRTAP6-1 (Two-hybrid), KRTAP6-1 (Two-hybrid), KRTAP6-1 (Two-hybrid), KRTAP6-1 (Two-hybrid), KRTAP6-1 (Two-hybrid), KRTAP6-1 (Two-hybrid), KRTAP6-1 (Two-hybrid)
ESM2 similar proteins: H2A0M6, O08632, O08633, O08640, P02448, P04459, P05685, P08826, P25692, P82170, P83358, Q02957, Q02958, Q28580, Q3LHN2, Q3LI54, Q3LI58, Q3LI59, Q3LI60, Q3LI61, Q3LI63, Q3LI64, Q3LI66, Q3LI67, Q3LI68, Q3LI70, Q3LI72, Q3LI73, Q3LI77, Q3MIV0, Q3SYF9, Q4W7G7, Q4W7G8, Q4W7G9, Q4W7H0, Q4W7H1, Q6F4C6, Q6R645, Q7Z4W3, Q8C1I6
Diamond homologs: Q3LI64, Q3LI66, Q3LI67, Q925H3
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 87 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Keratinization | 8 | 9.5× | 4e-04 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| anterior/posterior pattern specification | 6 | 14.5× | 5e-04 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
15 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 15 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
170 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 21:30613884:T:A | donor_gain | 0.8000 |
| 21:30613860:ATAG:A | donor_gain | 0.7900 |
| 21:30613903:A:C | donor_gain | 0.7900 |
| 21:30613880:AGTTT:A | donor_gain | 0.7800 |
| 21:30613893:G:C | donor_gain | 0.7800 |
| 21:30613895:TGCCA:T | donor_gain | 0.7600 |
| 21:30613878:G:C | donor_gain | 0.7500 |
| 21:30613863:G:C | donor_gain | 0.7100 |
| 21:30613897:C:CT | donor_gain | 0.7000 |
| 21:30613862:AG:A | donor_gain | 0.6900 |
| 21:30613877:A:AC | donor_gain | 0.6900 |
| 21:30613755:G:C | donor_gain | 0.6700 |
| 21:30613872:G:A | donor_gain | 0.6700 |
| 21:30613724:AG:A | donor_gain | 0.6600 |
| 21:30613855:A:T | donor_gain | 0.6600 |
| 21:30613899:A:T | donor_gain | 0.6600 |
| 21:30613581:T:TA | donor_gain | 0.6500 |
| 21:30613837:AGG:A | donor_gain | 0.6500 |
| 21:30613895:TGC:T | donor_gain | 0.6500 |
| 21:30613686:T:TA | donor_gain | 0.6400 |
| 21:30613853:A:AC | donor_gain | 0.6400 |
| 21:30613858:C:CT | donor_gain | 0.6400 |
| 21:30613754:AG:A | donor_gain | 0.6300 |
| 21:30613821:T:TA | donor_gain | 0.6300 |
| 21:30613826:AG:A | donor_gain | 0.6100 |
| 21:30613925:T:TA | donor_gain | 0.6100 |
| 21:30613842:T:TA | donor_gain | 0.6000 |
| 21:30613827:G:C | donor_gain | 0.5900 |
| 21:30613847:AG:A | donor_gain | 0.5900 |
| 21:30613852:CA:C | donor_gain | 0.5800 |
AlphaMissense
430 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 21:30613779:G:C | F42L | 0.857 |
| 21:30613779:G:T | F42L | 0.857 |
| 21:30613781:A:G | F42L | 0.857 |
| 21:30613769:C:G | G46R | 0.664 |
| 21:30613763:C:G | G48R | 0.603 |
| 21:30613893:G:C | S4R | 0.602 |
| 21:30613893:G:T | S4R | 0.602 |
| 21:30613895:T:G | S4R | 0.602 |
| 21:30613901:A:G | C2R | 0.602 |
| 21:30613899:A:C | C2W | 0.592 |
| 21:30613756:C:T | G50D | 0.566 |
| 21:30613762:C:T | G48D | 0.565 |
dbSNP variants (sampled 300 via entrez): RS1001092125 (21:30615888 A>T), RS1002741151 (21:30615841 G>A), RS1002874265 (21:30613998 G>A,T), RS1003494580 (21:30613011 T>C), RS1004373699 (21:30613921 G>A), RS1006093814 (21:30615170 G>A), RS1006454122 (21:30615430 G>A,C), RS1008436894 (21:30615321 G>A), RS1009015718 (21:30615593 C>T), RS1010535796 (21:30613384 C>T), RS1011048021 (21:30614755 A>G), RS1011639356 (21:30613147 T>A,G), RS1013293883 (21:30614881 T>C), RS1017415412 (21:30615190 A>G), RS1018494598 (21:30613506 C>T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
6 total (human), top 6 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| CGP 52608 | affects binding, increases reaction | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Atrazine | increases expression | 1 |
| Phthalic Acids | increases methylation | 1 |
| Plant Extracts | decreases expression, affects cotreatment | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.